{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2016-03-23&answeringDeptId=17", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?date=2016-03-23&answeringDeptId=17", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2016-03-23&answeringDeptId=17&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2016-03-23&_page=0&answeringDeptId=17", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2016-03-23&answeringDeptId=17", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2016-03-23&answeringDeptId=17", "items" : [{"_about" : "http://data.parliament.uk/resources/484865", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/484865/answer", "answerText" : {"_value" : "<p>Sir Bruce Keogh, NHS England\u2019s Medical Director, has undertaken a review of the National Clinical Director (NCD) resource designed to focus clinical advisory resources on areas where major programmes of work are currently being taking forward, or areas identified as priorities for improvement. As a result of the review, NHS England has proposed to change the way in which clinical advice is received in speciality areas in the future, streamlining and strengthening its clinical advisory mechanisms in support of the Five Year Forward View and the National Health Service\u2019s key improvement priorities.<\/p><p>Whilst there will no longer be a specific NCD role for neurology, NHS England will continue to secure expert clinical advice from its Clinical Networks and through its relationships with professional bodies and by appointing clinical advisors. Access to advice will be through clinical leads and members of the NHS England-funded neurology clinical networks, the Neurology Clinical Reference Group and Royal Colleges. It is expected that these new arrangements will be in place shortly.<\/p><p>During 2016/17, the focus of NHS England\u2019s improvement efforts delivered through Strategic Clinical Networks will be on a smaller range of key national priorities, including cancer, mental health, diabetes, maternity and urgent and emergency care (with a focus on cardiovascular disease transformation). Whilst there is no additional funding nationally, clinical and local networks of care can determine what can be done at a local or regional level if it is considered a local or regional system priority. Nationally, the policy team is considering how key aspects of the work on neurology can be taken forward through alternative mechanisms and partners.<\/p><p>In addition, the Neurology Intelligence Network (NIN) is a joint partnership programme between Public Health England (PHE) and NHS England to support the generation and dissemination of neurology related health intelligence. PHE currently funds the on-going design, development and management of the NIN.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/127", "label" : {"_value" : "Biography information for Lord Prior of Brampton"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord Prior of Brampton"}
        , "dateOfAnswer" : {"_value" : "2016-04-04", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2016-04-04T15:18:44.137Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2016-03-23", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Neurology"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty\u2019s Government what assessment they have made of the impact on the NHS of NHS England cutting the role of National Clinical Director for Adult Neurology, and the end of national funding for neurological work by clinical networks.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/2503", "label" : {"_value" : "Biography information for Baroness Gale"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Baroness Gale"}
      ], "uin" : "HL7369"}
    , {"_about" : "http://data.parliament.uk/resources/484872", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/484872/answer", "answerText" : {"_value" : "<p>We have a range of conversations about key issues at Ministerial and official level with NHS England. NHS England is independent and the decision on a sugar levy on the National Health Service estate is a matter for them operationally. We are interested to see the results of their consultation on a sugar levy.<\/p><p> <\/p><p>The announcement of a soft drinks industry levy by the Chancellor in the Budget is the first step in our comprehensive Childhood Obesity Strategy, which will be launched in the summer, and gives companies strong incentives to reformulate their products.<\/p><p> <\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/127", "label" : {"_value" : "Biography information for Lord Prior of Brampton"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord Prior of Brampton"}
        , "dateOfAnswer" : {"_value" : "2016-04-04", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : {"_value" : "HL7376"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2016-04-04T15:14:38.14Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2016-03-23", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Sugar: Taxation"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty\u2019s Government, further to the Written Answer by Lord Prior of Brampton on 23 March (HL6926), whether the issue of the sugar tax to be introduced by NHS England in their own premises by 2020 was raised as part of their conversations with NHS England, and if so, by whom and which ministers were consequently informed.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4333", "label" : {"_value" : "Biography information for Lord Scriven"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Lord Scriven"}
      ], "uin" : "HL7375"}
    , {"_about" : "http://data.parliament.uk/resources/484873", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/484873/answer", "answerText" : {"_value" : "<p>We have a range of conversations about key issues at Ministerial and official level with NHS England. NHS England is independent and the decision on a sugar levy on the National Health Service estate is a matter for them operationally. We are interested to see the results of their consultation on a sugar levy.<\/p><p> <\/p><p>The announcement of a soft drinks industry levy by the Chancellor in the Budget is the first step in our comprehensive Childhood Obesity Strategy, which will be launched in the summer, and gives companies strong incentives to reformulate their products.<\/p><p> <\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/127", "label" : {"_value" : "Biography information for Lord Prior of Brampton"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord Prior of Brampton"}
        , "dateOfAnswer" : {"_value" : "2016-04-04", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : {"_value" : "HL7375"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2016-04-04T15:14:38.203Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2016-03-23", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Sugar: Taxation"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty\u2019s Government, further to the Written Answer by Lord Prior of Brampton on 23 March (HL6926), on what date the Department of Health was informed that NHS England was going to introduce a sugar tax in NHS premises by 2020.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4333", "label" : {"_value" : "Biography information for Lord Scriven"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Lord Scriven"}
      ], "uin" : "HL7376"}
    , {"_about" : "http://data.parliament.uk/resources/484874", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/484874/answer", "answerText" : {"_value" : "<p>NHS England is planning to treat 10,000 patients with chronic hepatitis C in 2016/2017.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/127", "label" : {"_value" : "Biography information for Lord Prior of Brampton"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord Prior of Brampton"}
        , "dateOfAnswer" : {"_value" : "2016-04-04", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2016-04-04T15:12:42.727Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2016-03-23", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Hepatitis"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty\u2019s Government how many hepatitis C patients NHS England is planning to treat in 2016\u201317.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1833", "label" : {"_value" : "Biography information for Lord Mancroft"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Lord Mancroft"}
      ], "uin" : "HL7377"}
    , {"_about" : "http://data.parliament.uk/resources/484875", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/484875/answer", "answerText" : {"_value" : "<p>The National Institute for Health and Care Excellence (NICE) specifically requires Operational Delivery Networks (ODNs) to prioritise hepatitis C patients on the basis of highest unmet clinical need, as part of a progressive rollout of treatments over the next five years.<\/p><p> <\/p><p>NHS England is funding providers to double the number of patients treated and this number will ensure the National Health Service fully meets in 2016/17 the patient numbers NICE set out for progressive rollout of the treatments at the time it published its guidance.<\/p><p> <\/p><p>NHS England has invested in a Commissioning for Quality and Innovation scheme to incentivise ODNs to meet their agreed rate of roll-out. If their treatment rates deviate from this agreed rate of treatment, they are no longer eligible for these incentives.<\/p><p> <\/p><p>In meeting the obligations of its Mandate, NHS England has set out a planning approach for hepatitis C that delivers access to NICE recommended treatment without disinvestment in other health services.<\/p><p> <\/p><p> <\/p><p><strong> <\/strong><\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/127", "label" : {"_value" : "Biography information for Lord Prior of Brampton"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord Prior of Brampton"}
        , "dateOfAnswer" : {"_value" : "2016-04-04", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2016-04-04T15:12:20.443Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2016-03-23", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "NHS England"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty\u2019s Government for what reason NHS England intends to treat only a specified number of patients in 2016\u201317, as defined by recently published run rates for operational delivery networks services.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1833", "label" : {"_value" : "Biography information for Lord Mancroft"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Lord Mancroft"}
      ], "uin" : "HL7378"}
    , {"_about" : "http://data.parliament.uk/resources/484876", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/484876/answer", "answerText" : {"_value" : "<p>Based on National Institute for Health and Care Excellence (NICE) modelling, NHS England has planned for 10,000 patients to be treated in 2016/17. No national registry exists for hepatitis C and as a result NICE estimates that the NHS should be treating 10,000 people based on the total number of people diagnosed with hepatitis C, their genotype, their treatment history and their disease severity, all of which impact on treatment eligibility.<\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/127", "label" : {"_value" : "Biography information for Lord Prior of Brampton"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord Prior of Brampton"}
        , "dateOfAnswer" : {"_value" : "2016-04-04", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2016-04-04T15:15:24.42Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2016-03-23", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Hepatitis: Drugs"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty\u2019s Government how many people diagnosed with hepatitis C are eligible for treatment under the National Institute for Health and Care Excellence guidance for new direct acting antiviral drugs.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1833", "label" : {"_value" : "Biography information for Lord Mancroft"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Lord Mancroft"}
      ], "uin" : "HL7379"}
    , {"_about" : "http://data.parliament.uk/resources/484877", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/484877/answer", "answerText" : {"_value" : "<p>NHS England has been rapidly working on their plans for access to treatment during 2016/17 following enactment of the National Institute for Health and Care Excellence technical appraisal guidance and has committed to produce an operational framework for the treatment of hepatitis C during 2016/17. This will set out NHS England\u2019s commitment to improving outcomes in hepatitis C across England.<\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/127", "label" : {"_value" : "Biography information for Lord Prior of Brampton"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord Prior of Brampton"}
        , "dateOfAnswer" : {"_value" : "2016-04-04", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : [{"_value" : "HL7381"}
        , {"_value" : "HL7382"}
        ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2016-04-04T15:16:52.327Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2016-03-23", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Hepatitis"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty\u2019s Government what plans they have to review their hepatitis C strategy in the light of other European countries' strategies for tackling hepatitis C.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1833", "label" : {"_value" : "Biography information for Lord Mancroft"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Lord Mancroft"}
      ], "uin" : "HL7380"}
    , {"_about" : "http://data.parliament.uk/resources/484878", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/484878/answer", "answerText" : {"_value" : "<p>NHS England has been rapidly working on their plans for access to treatment during 2016/17 following enactment of the National Institute for Health and Care Excellence technical appraisal guidance and has committed to produce an operational framework for the treatment of hepatitis C during 2016/17. This will set out NHS England\u2019s commitment to improving outcomes in hepatitis C across England.<\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/127", "label" : {"_value" : "Biography information for Lord Prior of Brampton"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord Prior of Brampton"}
        , "dateOfAnswer" : {"_value" : "2016-04-04", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : [{"_value" : "HL7380"}
        , {"_value" : "HL7382"}
        ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2016-04-04T15:16:52.39Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2016-03-23", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Hepatitis"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty\u2019s Government whether plans to introduce a hepatitis C improvement framework have been abandoned and, if so, why.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1833", "label" : {"_value" : "Biography information for Lord Mancroft"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Lord Mancroft"}
      ], "uin" : "HL7381"}
    , {"_about" : "http://data.parliament.uk/resources/484879", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/484879/answer", "answerText" : {"_value" : "<p>NHS England has been rapidly working on their plans for access to treatment during 2016/17 following enactment of the National Institute for Health and Care Excellence technical appraisal guidance and has committed to produce an operational framework for the treatment of hepatitis C during 2016/17. This will set out NHS England\u2019s commitment to improving outcomes in hepatitis C across England.<\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/127", "label" : {"_value" : "Biography information for Lord Prior of Brampton"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord Prior of Brampton"}
        , "dateOfAnswer" : {"_value" : "2016-04-04", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : [{"_value" : "HL7380"}
        , {"_value" : "HL7381"}
        ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2016-04-04T15:16:52.467Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2016-03-23", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Hepatitis"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty\u2019s Government what plans they have to ensure that the objectives of the hepatitis C improvement framework can still be achieved.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1833", "label" : {"_value" : "Biography information for Lord Mancroft"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Lord Mancroft"}
      ], "uin" : "HL7382"}
    , {"_about" : "http://data.parliament.uk/resources/485534", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/485534/answer", "answerText" : {"_value" : "<p>The Department assesses the impact of all proposed measures before laying legislation using standard government methodology. These assessments are set out in Impact Assessments which are scrutinised by the Regulatory Policy Committee before publication alongside the Statutory Instrument. Impact Assessments include a thorough analysis of the costs, benefits and risks associated with policy options.<\/p><p>A number of the tobacco measures contain commitments to further review the impact of the legislation within five years of them coming into force.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
        }
        , "answeringMemberConstituency" : {"_value" : "Battersea"}
        , "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
        , "dateOfAnswer" : {"_value" : "2016-04-11", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : {"_value" : "32264"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2016-04-11T08:49:14.093Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2016-03-23", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Tobacco"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health, what the cumulative loss in revenue to HM Treasury has been as a result of the effect of tobacco control measures over the last 10 years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/245", "label" : {"_value" : "Biography information for Sir Robert Syms"}
      }
      , "tablingMemberConstituency" : {"_value" : "Poole"}
      , "tablingMemberPrinted" : [{"_value" : "Mr Robert Syms"}
      ], "uin" : "32263"}
    ], "itemsPerPage" : 10, "next" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2016-03-23&_page=1&answeringDeptId=17", "page" : 0, "startIndex" : 1, "totalResults" : 67, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}